Celularity Inc. vs Pulike Biological Engineering, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pulike Biological Engineering, Inc. is the larger company by market value: $524 M against $28 M for Celularity Inc., 19 times as much (market caps of Oct 30, 2026 for Celularity Inc. and Aug 1, 2026 for Pulike Biological Engineering, Inc.). Pulike Biological Engineering, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Celularity Inc. CELU · #23,315 in the world | Pulike Biological Engineering, Inc. 603566.SS · #12,320 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇨🇳 China |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $28 M | $524 M |
| Revenue | $27 M | — |
| Net income | $-92 M | — |
| Employees | 288 | — |
| Valuation | ||
| Price to sales | 1.5× | — |
| Free cash flow yield | -23.8% | — |
| Profitability | ||
| Gross margin | 24.4% | — |
| Operating margin | -230.9% | — |
| Net margin | -345.5% | — |
| Growth | ||
| Revenue growth | -51.0% | — |
| Revenue growth, 3 years a year | 13.9% | — |
| Altman Z-score zone | distress | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026 |
Questions and answers#
Which is bigger, Celularity Inc. or Pulike Biological Engineering, Inc.?
Pulike Biological Engineering, Inc. is the larger company by market value: $524 M against $28 M for Celularity Inc., 19 times as much (market caps of Oct 30, 2026 for Celularity Inc. and Aug 1, 2026 for Pulike Biological Engineering, Inc.). Pulike Biological Engineering, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.